Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Nicolas Chomont, chair of CROI 2026’s scientific program, previewed the conference’s focus on emerging HIV research, including treatment, cure, and vaccine advances. The meeting will showcase extensive data on long‑acting antiretroviral therapies and address funding constraints affecting global HIV initiatives. CROI also emphasizes collaboration, offering scholarships to 243 early‑career investigators worldwide. The conference remains a pivotal platform for shaping clinical practice, policy, and future research directions.
The Guttmacher Institute reports a modest 2% drop in abortion clinics across non‑ban states, yet high churn—51 closures and 39 openings—creates instability, especially in Florida where a six‑week ban accelerated losses despite telehealth growth. New sickle‑cell disease therapies, including gene‑editing...
Hospitals and Area Agencies on Aging (AAAs) are launching joint programs to combat social isolation among older adults, a risk heightened by the fact that one‑fifth of Americans 50+ live alone. The collaborations leverage community health workers, technology platforms, and...
GoFundMe’s CEO Tim Cadogan says health‑related fundraising remains the platform’s top category, with campaigns like the late actor James Van Der Beek’s raising $2.7 million. The company allows anyone facing out‑of‑pocket medical costs to start a fundraiser without disclosing personal financial details. Cadogan and...
The CDC’s February 19 MMWR report shows that only a minority of Americans aged 65 and older received FDA‑approved COVID‑19 antiviral prescriptions in recent months. From June 2023 through September 2025, antiviral use was 16‑23% during periods of low community transmission and rose...
Medtronic reported Q3 2026 adjusted earnings of $1.36 per share, beating expectations, while revenue climbed 8.7% to $9.0 billion, led by a 13.8% surge in its cardiovascular unit. Operating margin slipped to 16.2% from 19.9% as the company intensified R&D spending...
Ten63 Therapeutics, an AI‑driven drug‑discovery firm spun out of Duke and TTIC, announced a strategic investment from Chugai Venture Fund and the Bill & Melinda Gates Foundation, bringing total capital to over $45 million. The company leverages its BEYOND generative‑chemistry platform...
The U.S. FDA has approved an expanded label for Guerbet’s gadolinium‑based contrast agent Elucirem (gadopiclenol), allowing its use in infants and children under two years, including term neonates. The agent delivers high‑relaxivity imaging with less than half the gadolinium dose...
Researchers at Michigan State University discovered that hormone‑regulated monocytes producing interleukin‑10 (IL‑10) drive faster pain resolution in males. In mouse models, testosterone‑dependent IL‑10+ monocytes cleared inflammatory pain more quickly, while females exhibited fewer of these cells and prolonged pain. Human...
Danish startup OptikosPrime claims its Argus app can generate a full eyeglass prescription using only a smartphone camera. In prototype tests the app achieved a mean absolute error of 0.51 diopters, approaching the 0.25‑diopter threshold of professional autorefractors. The solution...
The latest ceftriaxone injection labeling clarifies susceptibility breakpoints for anaerobic organisms, defining a minimum inhibitory concentration of ≤1 µg/mL as susceptible. For Haemophilus influenzae and H. parainfluenzae, the interpretive criteria assume a 2 g IV dose every 24 hours in patients with normal...
The HIMSS26 conference will host the fourth Native American & Indigenous Health Symposium, bringing together tribal and Indigenous health leaders from the U.S., Canada, Australia and Alaska. Since its 2022 launch, the HIMSS Indigenous Community has expanded its network and...
A public‑private partnership between the University of Kansas Health System, KU Medical Center, Children’s Mercy and Bold Advanced Medical Future (BAMF) Health is launching an integrated theranostics platform in Kansas City. The center will combine molecular imaging, radiopharmaceutical production, clinical...
Science Applications International Corp. (SAIC) has launched the Alliance for Advancing Rural Healthcare (AARH), uniting seven partners—including Arcadia, Castlight Health, Covista, Mission Mobile Medical, Telemedicine.com, TruBridge and Walgreens—to execute the $50 billion Rural Health Transformation program. The alliance will bolster the...
At the India AI Impact Summit 2026, Maverick Simulation Solutions unveiled LuSI, a 2.5 kg AI‑integrated robotic newborn that replicates real‑time respiratory conditions for high‑fidelity medical training, already adopted by AIIMS, AFMC and PGI. The same event highlighted PhonePe's launch of...
athenahealth unveiled the next generation of its AI‑native patient engagement suite within athenaOne, adding text and voice virtual assistants that let patients schedule appointments and ask routine questions 24/7. The texting feature is in alpha and will roll out broadly...
The February 20 2026 "In the Clinic" roundup aggregates a broad set of industry snapshots, special reports, and infographics covering biopharma, medical technology, and emerging research areas. It links to data on mRNA vaccine research, China’s GLP‑1 market, pulsed‑field ablation for atrial...
Recent biopharma research highlights IL‑22 and TL1A as a powerful biomarker pair for diagnosing hidradenitis suppurativa (HS), while TL1A overexpression is confirmed in patient lesions. Parallel studies reveal that inhibiting the NLRP3 inflammasome may mitigate vascular cognitive impairment and stroke‑related...
A study published in Investigative Ophthalmology & Visual Science shows that a single yes‑or‑no question can reliably screen for low vision and legal blindness, achieving area‑under‑the‑curve (AUC) values of 0.81 and 0.77 respectively. Researchers tested 385 adults across four U.S....
Encompass Health and Enhabit secured a $43.1 million award covering attorneys’ fees and mitigation damages after a Delaware federal judge ruled that 43% of VitalCaring’s profits and any future sale proceeds must be placed in a trust for the two companies....
On April 22‑23, 2026, the FDA’s Center for Drug Evaluation and Research hosted the annual Generic Drugs Forum at its White Oak Campus, with a virtual option via Adobe Connect. The two‑day event gathered generic drug developers, consultants, and regulatory...
Akido Labs has deployed an AI‑native platform that equips community health workers with real‑time data collection, documentation, and patient‑engagement tools for street‑medicine teams. The model aligns with California’s CalAIM whole‑person care framework and shifts the heavy reporting burden away from...
CRM migrations in healthcare and life sciences are accelerating amid tighter regulations such as HIPAA, GDPR, and FDA 21 CFR Part 11. Avenga’s Roman Bevz outlines a compliance‑by‑design methodology that starts with mapping data to regulatory obligations and proceeds through risk analysis,...
Programs for All‑Inclusive Care of the Elderly (PACE) remain among the most complex value‑based models to launch, demanding multi‑million dollar capital, state contracts, and intricate regulatory compliance. SCAN Group’s myPlace Health, now fully owned after buying out Commonwealth Care Alliance,...
Researchers coated magnetic silica nanoparticles with membranes from naïve (M0), classically activated (M1) and alternatively activated (M2) macrophages to study phenotype‑dependent protein corona formation. Proteomic analysis showed M0‑derived membranes adsorbed the fewest opsonins (C3, IgG, IgM) and triggered the lowest...
Senseonics and Sequel Med Tech have launched an automated insulin‑delivery system that pairs the year‑long Eversense 365 implantable CGM with Sequel’s twiist pump. The integration, delayed to Q4 2025, marks the first AID solution using a one‑year sensor, contrasting with competitors’ 15‑day...
The American Hospital Association (AHA) is intensifying its fight against violence in health‑care settings by releasing a joint guide with the FBI on behavioral threat assessment and management (BTAM). The guide provides evidence‑based strategies, training recommendations, and case studies from...
At the 2026 EAPCI Summit, experts highlighted AI’s expanding role in cardiovascular interventions, from mortality risk modeling to intravascular imaging analysis. A University of Galway study identified gamma‑glutamyl transferase as a strong 10‑year mortality predictor in the SYNTAX cohort, validated...
Researchers have created an injectable dual‑network hydrogel composed of gelatin methacrylate and κ‑carrageenan that embeds quercetin‑loaded PLGA nanoparticles for mesenchymal stem cell (MSC) delivery in osteoarthritis (OA). The antioxidant hydrogel scavenges reactive oxygen species, reprograms M1 macrophages to an anti‑inflammatory...
The article outlines modern pediatric fluid and electrolyte therapy, emphasizing isotonic maintenance IV solutions to curb hyponatremia and detailing the Holliday‑Segar and BSA‑based calculation methods. It differentiates oral rehydration for mild‑to‑moderate dehydration from phased isotonic bolus and deficit‑plus‑maintenance IV regimens...
FDA drug‑center head Tracy Beth Høeg used her first staff address to flag two priority areas: the safety of antidepressants taken during pregnancy and the use of monoclonal antibodies that protect infants from RSV. She also signaled a continued interest...
Surgery centers are expanding rapidly, but growth brings regulatory, staffing, and technology challenges that can overwhelm internal teams. Without a structured plan, new service lines often trigger credentialing, supply chain, and workflow gaps, leading to delays and cost overruns. Ambulatory...
Chief Clinical Officer Dr. Michael Zappa of Cape Fear Valley Health, also a physician advisor at Juno Health, urges healthcare leaders to directly ask clinicians which administrative duties pull them away from patient care. He recommends mapping these tasks and...
The FDA has placed Regeneron's anti‑activin A antibody garetosmab under priority review, with a decision expected by August. Phase 3 OPTIMA data showed a 94% reduction in new heterotopic ossification lesions at the lower dose and a 90% reduction at the higher...
Frontline treatment of diffuse large B‑cell lymphoma (DLBCL) is shifting from traditional R‑CHOP toward targeted and bispecific antibody‑based regimens. The POLARIX phase‑3 trial demonstrated that Pola‑R‑CHP improves progression‑free survival, particularly in activated‑B‑cell (ABC) disease and older patients. Early phase studies...
Researchers have unveiled a nanozyme‑aptamer colorimetric array that classifies Staphylococcus aureus strains with 100% accuracy, including methicillin‑resistant variants. The platform couples gold‑nanoparticle nanozymes with four strain‑specific aptamers, producing distinct color fingerprints that are decoded by hierarchical clustering and linear discriminant...
Community Health Systems (CHS) announced it will decelerate its aggressive divestiture program as it focuses on strengthening core markets. The for‑profit hospital chain has cut its debt leverage to 6.6× in 2025, down from 7.4× the year before, and boosted...
A British Columbia privacy commissioner report revealed 36 healthcare workers accessed patient records in 71 separate incidents, highlighting a broader issue of employee snooping. Privacy lawyer Lyndsay Wasser says such unauthorized access is common across sectors, not limited to high‑profile...
The Centers for Medicare & Medicaid Services released draft ACA rules for 2027 that could make individual major‑medical coverage cheaper and more attractive. Key changes include broader availability of catastrophic plans, higher annual out‑of‑pocket caps, and the option for monthly...
Merck is expanding beyond its flagship Keytruda by investing in diverse oncology platforms. In 2024 it spent $700 million on a bispecific candidate from Curon and $680 million to acquire Harpoon Therapeutics, bolstering its T‑cell engager portfolio. The company is also advancing...
The FDA approved a fixed‑dose combination of acalabrutinib (Calquence) and venetoclax (Venclexta) for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. The decision is based on the AMPLIFY trial, which showed a 35% reduction in progression‑free survival risk compared...
The U.S. FDA has accepted Roche’s new drug application for giredestrant combined with everolimus to treat ER‑positive, HER2‑negative, ESR1‑mutated advanced breast cancer. Phase III evERA data show a 44% reduction in disease progression or death overall and a 62% reduction in...
A shortage of bone cement from German supplier Heraeus Medical threatens NHS orthopaedic surgeries, potentially lasting two months. NHS England has asked trusts to prioritise emergency joint replacements, leaving elective patients at risk. UK‑based Biocomposites accelerated the launch of its...
Novartis announced the sale of its majority stake in its Indian generics and prescription business to a private‑equity‑led consortium for $159 million. The transaction transfers control of a portfolio that includes both off‑patent generics and branded medicines to the buyers. The...
Stratasys unveiled a new dental anatomical model preset that leverages its multi‑material 3D printing platform to produce highly detailed, biomechanically accurate replicas for dental education and device training. The preset standardizes material ratios and printing parameters, enabling on‑demand, repeatable models...
Kontakt.io announced a suite of AI‑driven agents at ViVE 2026, combining real‑time location services (RTLS) with electronic health record data to create a digital twin of hospital operations. The portfolio—Patient Journey Analytics, Access Agent, Patient Flow Agent, and Supply Chain...
Pontiro, a health‑tech firm that streamlines medical‑image data for AI, secured £357,500 in a round led by SFC Capital with participation from Plug and Play Ventures and the British Business Bank. The company’s platform has already processed more than two...
Daiichi Sankyo appointed former Novartis chief medical officer John Tsai as its new CMO, succeeding Ken Takeshita after a five‑year tenure. Tsai brings a record of launching 160 projects and 15 regulatory approvals, including Zolgensma and Pluvicto, and recent experience leading biotech...
U.S. FDA has granted IND clearance for NexEos Bio’s ophthalmic solution NTX-1024, allowing the company to commence a combined Phase II/III clinical trial in vernal keratoconjunctivitis (VKC). The upcoming study will assess safety and efficacy after an open‑label investigator‑initiated trial...
Boehringer Ingelheim India has signed a memorandum of understanding with the National Institute of Pharmaceutical Education and Research (NIPER) in Raebareli to deepen collaboration on pharmaceutical technologies and novel drug delivery systems. The agreement grants NIPER access to Boehringer’s opnMe...
